Home / Nervous system / Agomelatine
ATC N06AX22 · Other Antidepressants
Agomelatine shortage
As of 2 Nov 2026, Agomelatine has a reported shortage in 1 of the 16 countries we track (Czechia), covering 3 products from 2 companies.
Countries1/16
Products3packs or presentations
Companies21 listed
Short since27 Apr 20266 months ago
Earliest return1 Jan 2027company estimate
Main reasonCommercial decision or withdrawal
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia3 products shortNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
Czechia
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Glenmark GLENMARK · NSE
Compared with similar medicines
ATC group N06AX · Other AntidepressantsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | AGOMELATIN +PHARMA 25MG 25MG TBL FLM 98 | +pharma arzneimittel gmbh, Graz | 27 Apr 2026 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | AGOMELATIN +PHARMA 25MG 25MG TBL FLM 90 | +pharma arzneimittel gmbh, Graz | 1 Jul 2026 | 3 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | AGOMELATINE GLENMARK 25MG 25MG TBL FLM 28 anticipated | Glenmark Pharmaceuticals s.r.o., Praha | 9 Nov 2026 | 1 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.